BIIB
Biogen Stock Analysis
AI Rating
- Quality8/10
- Growth↑ 5/10
- Value↑ 5/10
BIIB Growth
- Revenue Y/Y↓ 2.22%
- EPS Y/Y↓ -21.23%
- FCF Y/Y↓ -22.47%
BIIB Profitability
- Gross margin ↑ 75.70%
- EPS margin↑ 13.10%
- ROIC 5Y↓ 13.55%
BIIB Risk
- Debt / Equity↓ 0.4
- Debt / FCF↓ 1.8
- Interest coverage↑ 999.0
Biogen stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.